VRDN — VIRIDIAN THERAPEUTICS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 244 SEC-registered investment managers reported holding VRDN (VIRIDIAN THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $2.44B across 301.56M shares. That is +68.1% by share count (+73.34M shares) versus the previous quarter, while reported value moved +4.5%. Ownership is concentrated: the five largest holders account for 31.8% of reported value and the top ten for 46.5%.
Compared with the prior quarter, 64 opened new positions, 100 added to existing stakes, 53 trimmed, 52 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of VIRIDIAN THERAPEUTICS INC (VRDN) include Fidelity Management & Research (FMR), Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, ranked by reported 13F value among the 440 institutional holders on this page.
VRDN is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 169 | 154.93M | $1.32B | +19.1% |
| Q2 2026 | 244 | 301.56M | $2.44B | +68.1% |
| Q1 2026 | 232 | 118.41M | $2.26B | +4.6% |
| Q4 2025 | 232 | 114.44M | $3.45B | +9.3% |
| Q3 2025 | 170 | 99.36M | $2.09B | -0.5% |
| Q2 2025 | 171 | 99.84M | $1.36B | +4.1% |
| Q1 2025 | 177 | 95.81M | $1.27B | +1.6% |
| Q4 2024 | 178 | 92.99M | $1.76B | +6.2% |
Over the 8 quarters shown, institutional share counts increased 67% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q2 2026 (+68.1%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 17.51M | $360.51M | 0.02% | Add | |
| 7.20M | $131.41M | 0.00% | Add | |
| 5.10M | $103.47M | 0.00% | Add | |
| 3.29M | $64.38M | 0.00% | Add | |
| 4.50M | $61.83M | 9.80% | New | |
| 49.00M | $56.47M | 1.87% | Add | |
| 2.42M | $49.77M | 0.00% | Reduce | |
| 1.75M | $36.11M | 0.01% | Add | |
| 1.53M | $31.55M | 0.14% | Reduce | |
| 1.58M | $22.42M | 4.21% | Add | |
| 19.46M | $22.26M | 0.74% | Add | |
| 972.94K | $20.03M | 0.01% | Reduce | |
| 1.04M | $19.37M | 0.00% | Add | |
| 6.83M | $17.59M | 0.00% | Add | |
| 1.25M | $17.16M | 2.73% | New | |
| 1.22M | $16.82M | 0.02% | New | |
| 806.17K | $16.59M | 0.00% | Add | |
| 1.20M | $16.47M | 0.76% | New | |
| 700.57K | $14.42M | 0.02% | Reduce | |
| 722.93K | $13.52M | 0.01% | Reduce | |
| 918.76K | $12.61M | 8.52% | New | |
| 860.34K | $11.81M | 4.81% | New | |
| 560.71K | $11.55M | 2.25% | New | |
| 532.33K | $10.96M | 0.30% | Reduce | |
| 483.35K | $9.95M | 0.00% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 15.38M | $300.82M | 0.02% | Add | |
| 7.83M | $153.18M | 0.01% | Add | |
| 6.73M | $131.56M | 3.13% | Add | |
| 4.67M | $91.40M | 0.00% | Add | |
| 4.17M | $81.51M | 0.00% | New | |
| 3.91M | $76.57M | 5.53% | Hold | |
| 3.88M | $75.95M | 2.83% | Hold | |
| 3.21M | $62.71M | 0.01% | Reduce | |
| 3.15M | $61.59M | 1.26% | Add | |
| 3.08M | $60.22M | 0.01% | Add | |
| 3.08M | $60.22M | 0.01% | Add | |
| 2.34M | $45.80M | 2.95% | Add | |
| 2.33M | $45.65M | 0.00% | Add | |
| 2.32M | $45.30M | 0.15% | Add | |
| 1.39M | $43.32M | 0.01% | Reduce | |
| 2.00M | $39.12M | 3.17% | Reduce | |
| 1.97M | $38.57M | 0.23% | Hold | |
| 1.79M | $35.06M | 1.78% | Hold | |
| 1.77M | $34.59M | 0.01% | Reduce | |
| 1.64M | $32.11M | 0.00% | New | |
| 1.59M | $31.14M | 0.01% | Add | |
| 1.50M | $29.34M | 0.36% | Hold | |
| 1.39M | $27.27M | 0.45% | Reduce | |
| 1.26M | $24.70M | 0.02% | Add | |
| 1.26M | $24.70M | 0.05% | Add |
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 14.38M | $447.64M | 0.02% | Add | |
| 6.43M | $200.16M | 0.01% | Add | |
| 5.61M | $174.65M | 0.00% | Add | |
| 4.36M | $135.64M | 2.57% | New | |
| 3.91M | $121.82M | 9.27% | Add | |
| 3.88M | $120.83M | 5.97% | Hold | |
| 3.47M | $107.88M | 0.00% | Add | |
| 3.44M | $107.04M | 0.01% | Add | |
| 3.04M | $94.69M | 1.79% | Add | |
| 2.52M | $78.57M | 1.40% | Reduce | |
| 2.38M | $74.07M | 5.75% | Hold | |
| 1.99M | $62.01M | 0.00% | Add | |
| 1.97M | $61.36M | 0.38% | Add | |
| 1.97M | $61.35M | 0.01% | Add | |
| 1.97M | $61.35M | 0.01% | Add | |
| 1.79M | $55.79M | 2.76% | Reduce | |
| 1.78M | $55.46M | 2.79% | Reduce | |
| 1.78M | $55.40M | 0.02% | Add | |
| 1.74M | $54.09M | 0.00% | Add | |
| 1.50M | $46.68M | 0.51% | New | |
| 1.48M | $46.09M | 0.06% | Reduce | |
| 1.47M | $45.76M | 3.06% | Reduce | |
| 1.44M | $44.91M | 1.15% | Reduce | |
| 1.41M | $44.01M | 0.01% | Reduce | |
| 1.38M | $42.81M | 0.06% | Add |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 12.25M | $264.34M | 0.01% | Hold | |
| 5.43M | $117.15M | 0.00% | Reduce | |
| 5.38M | $116.11M | 3.24% | Hold | |
| 4.43M | $95.55M | 7.11% | Hold | |
| 4.33M | $93.48M | 0.00% | Reduce | |
| 3.88M | $83.79M | 4.72% | Hold | |
| 3.46M | $74.66M | 6.72% | Hold | |
| 3.20M | $69.06M | 3.37% | Reduce | |
| 2.84M | $61.35M | 2.36% | Hold | |
| 2.61M | $56.31M | 1.88% | Reduce | |
| 2.55M | $55.12M | 0.00% | Hold | |
| 2.42M | $52.18M | 0.01% | Reduce | |
| 2.38M | $51.36M | 3.31% | Hold | |
| 2.21M | $47.75M | 0.65% | Reduce | |
| 2.21M | $47.75M | 0.64% | Reduce | |
| 1.92M | $41.53M | 3.09% | Add | |
| 1.86M | $40.13M | 0.01% | Reduce | |
| 1.77M | $38.12M | 0.00% | Add | |
| 1.74M | $37.64M | 0.28% | Hold | |
| 1.55M | $33.46M | 0.04% | Add | |
| 1.46M | $31.56M | 0.95% | Add | |
| 1.22M | $26.33M | 0.04% | Add | |
| 1.20M | $25.92M | 0.01% | Add | |
| 1.15M | $24.91M | 2.60% | Reduce | |
| 1.12M | $24.22M | 0.01% | Add |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 12.24M | $171.10M | 0.01% | Hold | |
| 5.52M | $77.18M | 0.00% | Reduce | |
| 5.38M | $75.22M | 2.42% | Hold | |
| 4.88M | $68.15M | 4.81% | Add | |
| 4.51M | $63.03M | 0.00% | Reduce | |
| 4.43M | $61.90M | 6.67% | Reduce | |
| 3.88M | $54.28M | 4.07% | Hold | |
| 3.46M | $48.37M | 6.27% | Hold | |
| 2.90M | $40.48M | 0.01% | Add | |
| 2.84M | $39.74M | 2.01% | Add | |
| 2.74M | $38.33M | 1.64% | Add | |
| 2.55M | $35.70M | 0.00% | Reduce | |
| 2.38M | $33.27M | 2.35% | Add | |
| 2.26M | $31.55M | 0.48% | Add | |
| 2.26M | $31.55M | 0.47% | Add | |
| 1.94M | $27.18M | 0.01% | Reduce | |
| 1.90M | $26.60M | 2.45% | Add | |
| 1.74M | $24.39M | 0.24% | New | |
| 1.74M | $24.34M | 0.00% | Add | |
| 1.34M | $18.71M | 0.02% | Reduce | |
| 1.30M | $18.16M | 2.09% | Add | |
| 1.27M | $17.70M | 0.02% | Add | |
| 1.21M | $16.89M | 0.03% | Add | |
| 1.11M | $15.50M | 0.03% | Reduce | |
| 982.58K | $13.74M | 1.41% | Hold |
New Positions (Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 2.50M sh · $45.97M
- Context Capital Management, LLC 40.75M sh · $43.82M
- Caligan Partners LP 2.19M sh · $40.30M
- Polar Asset Management Partners Inc. 22.50M sh · $24.14M
- Sixth Street Partners Management Company, L.P. 815.03K sh · $14.97M
- Schonfeld Strategic Advisors LLC 793.51K sh · $14.58M
- DeepCurrents Investment Group LLC 11.96M sh · $12.78M
- BOOTHBAY FUND MANAGEMENT, LLC 541.06K sh · $9.94M
- EMERALD ADVISERS, LLC 537.33K sh · $9.87M
- Ikarian Capital, LLC 425.00K sh · $7.81M
- TENOR CAPITAL MANAGEMENT Co., L.P. 7.00M sh · $7.53M
- EMERALD MUTUAL FUND ADVISERS TRUST 395.55K sh · $7.27M
Fully Exited (vs previous quarter)
- STATE STREET CORP sold 4.67M sh · $91.40M
- ADAGE CAPITAL PARTNERS GP, L.L.C. sold 970.02K sh · $18.97M
- LOOMIS SAYLES & CO L P sold 927.72K sh · $18.15M
- MPM BioImpact LLC sold 649.87K sh · $12.71M
- ExodusPoint Capital Management, LP sold 330.39K sh · $6.46M
- ADAR1 Capital Management, LLC sold 304.42K sh · $5.95M
- Davern Capital Partners, LP sold 302.46K sh · $5.92M
- RAYMOND JAMES FINANCIAL INC sold 293.31K sh · $5.45M
- Marshall Wace sold 269.59K sh · $5.27M
- Qube Research & Technologies Ltd sold 231.27K sh · $4.52M
- Propel Bio Management, LLC sold 210.16K sh · $4.09M
- Vivo Capital, LLC sold 166.29K sh · $3.25M
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fidelity Management & Research (FMR) | 17.51M | 16.60M | 15.38M | 14.38M | 12.25M | 12.24M | 12.22M | 11.88M | 11.18M | 9.57M | 9.42M | 7.63M | 262.19K | 261.76K | 144.15K | 1.20K | 443 | 69 | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 7.20M | 4.58M | 4.17M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 5.10M | — | 4.67M | 3.47M | 2.55M | 2.55M | 2.87M | 3.52M | 2.38M | 2.77M | 4.49M | 2.71M | 2.94M | — | — | — | — | — | — | — |
| Geode Capital Management | 3.29M | 2.50M | 2.33M | 1.99M | 1.77M | 1.74M | 1.72M | 1.66M | 1.49M | 1.41M | 1.16M | 994.47K | 859.10K | 860.86K | 776.11K | 710.99K | 599.77K | 449.66K | 199.24K | 201.68K |
| Atlas Venture Life Science Advisors, LLC | 4.50M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Context Capital Management, LLC | 49.00M | 40.75M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.42M | 2.75M | 1.64M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| DIMENSIONAL FUND ADVISORS LP | 1.75M | 1.61M | 529.76K | 555.59K | 638.78K | 485.70K | — | 55.92K | 327.08K | 107.58K | 10.07K | 10.07K | 10.07K | — | — | — | — | — | — | — |
| Candriam S.C.A. | 1.53M | 1.71M | 711.74K | 785.10K | 860.23K | 862.27K | 880.43K | 731.22K | 749.80K | 749.80K | 280.00K | — | — | — | — | — | — | — | — | — |
| Blue Owl Capital Holdings LP | 1.58M | 260.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| DeepCurrents Investment Group LLC | 19.46M | 11.96M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Arrowstreet Capital | 972.94K | 1.11M | 23.28K | 341.26K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 1.04M | 657.59K | 591.23K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BlackRock Inc | 6.83M | 6.05M | 7.83M | 6.43M | 5.43M | 5.52M | 5.71M | 5.76M | 4.80M | — | — | — | — | — | — | — | — | — | — | — |
| Spruce Street Capital LP | 1.25M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Alphabet Inc. | 1.22M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Morgan Stanley | 806.17K | 728.82K | 870.16K | 1.74M | 191.94K | 200.37K | 341.80K | 739.14K | 1.01M | 320.57K | 562.54K | 524.90K | 333.72K | 69.68K | 433.13K | 335.30K | 164.76K | 27.58K | 34.93K | 13.70K |
| Nantahala Capital Management, LLC | 1.20M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BNP PARIBAS FINANCIAL MARKETS | 700.57K | 1.01M | 266.40K | 517.40K | 242.31K | 190.23K | 138.86K | 203.85K | — | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 722.93K | 1.43M | 307.13K | 164.82K | 447.68K | 533.64K | 504.19K | 512.07K | 84.73K | 230.38K | 379.58K | 143.39K | 68.42K | 79.58K | 68.79K | 145.78K | 49.30K | 13 | 222 | 13 |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold VRDN?
As of 2026-Q2, 244 institutional funds reported holding VRDN (VIRIDIAN THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $2.44B.
How many shares of VRDN do institutions own?
13F filers reported 301.56M shares of VRDN, worth $2.44B in aggregate at the end of 2026-Q2.
Is institutional ownership of VRDN rising or falling?
Share counts moved +68.1% versus the prior quarter — accumulation.
Who are the top institutional holders of VRDN?
The largest 13F holders are Fidelity Management & Research (FMR), Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, Bellevue Group AG, Paradigm Biocapital Advisors LP; the top 25 are ranked at the top of this page.
Who are the major shareholders of VIRIDIAN THERAPEUTICS INC?
The major shareholders of VIRIDIAN THERAPEUTICS INC (VRDN) by reported 13F value are Fidelity Management & Research (FMR), Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, Bellevue Group AG, Paradigm Biocapital Advisors LP, among 440 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.